Cabergoline
Cabergoline Tablets USP Rx only
Approved
Approval ID
c9f0b576-d5e5-4e3e-bb5c-3574d75d9907
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 16, 2021
Manufacturers
FDA
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cabergoline
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50090-3157
Application NumberANDA077750
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cabergoline
Product Specifications
Route of AdministrationORAL
Effective DateJuly 31, 2020
FDA Product Classification
INGREDIENTS (3)
CABERGOLINEActive
Quantity: 0.5 mg in 1 1
Code: LL60K9J05T
Classification: ACTIB
LEUCINEInactive
Code: GMW67QNF9C
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT